Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Family-oriented setup guidance to allocate every dollar and align spending with collective priorities.
19,524 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Explore what drives brookdale (bkd) 2025 earnings, how occupancy, rates, and costs shape profits, and practical steps...
Royal Caribbean deploys AI to forecast demand, trim waste, and tailor guest experiences, signaling a data-driven shif...
When a notable manager trims a stake in a popular ETF, it can offer clues about risk, opportunity, and the broader ma...
Constellation Energy stock climbing today reflects a mix of solid quarterly results and favorable energy-market dynam...
Novo Nordisk stock faced renewed selling pressure this week as investors weighed trial results and government-driven ...
When a quarterly miss hits the wires, investors scramble to interpret the fallout. This deep dive explains why calume...
Analysts upgrade CrowdStrike ahead of earnings, citing modest guidance risk and a software sector pullback that has w...
As electric-vehicle charging scales up, ChargePoint's 2026 earnings outlook becomes a key signal for investors. This ...
The Real Brokerage is expanding its leadership with the appointment of Jason Cassity as Chief Growth Officer, a move ...
Could AI excitement be lifting prices beyond fundamentals? This guide flags three warning signs and offers actionable...